101. Molecular Mechanism of Gleditsiae Spina for the Treatment of High-grade Serous Ovarian Cancer Based on Network Pharmacology and Experimental Verification
- Author
-
Bo-Ran Zhang, Xing Chen, Cun-Fang Dai, Ting-Ting Ma, Xiaomin Wang, Xinjie Chen, Guangda Li, Ganlin Zhang, Wenchao Dan, and Xiaohui Yin
- Subjects
business.industry ,Network pharmacology ,Molecular mechanism ,Cancer research ,Serous ovarian cancer ,Medicine ,business - Abstract
Background In this study, we aimed to analyze the pharmacological mechanism of Gleditsiae Spina in the treatment of high-grade serous ovarian cancer (HGSC) based on network pharmacology and in vitro experiments. Methods The main active ingredients of Gleditsiae Spina were identified by high performance liquid chromatography and mass spectrometry, and ADME screening was performed. The component targets of Gleditsiae Spina were screened using the pharmMapper platform, and differentially expressed genes in normal and HGSC tissues were identified through GEO database. Thereafter, Cytoscape 3.7.2 software was used to construct the network of "active ingredient-targets," and the BioGenet database was used for protein-protein interaction analysis. Furthermore, the protein-protein interaction network was established, and the potential protein function module was mined. Biological processes and pathways were analyzed through gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis. Results The core active ingredients of Gleditsiae Spina for regulating HGSC included luteolin, genistein, D-(+)-tryptophan, ursolic acid, and berberine. The ideal targets were HPSE, PI3KCA, AKT1, and CTNNB1. The prediction results were verified by molecular docking, molecular dynamics simulation, and western blot analysis. Conclusions This study revealed the mechanism of Gleditsiae Spina for the treatment of HGSC based on multi-components, multi-targets, and multi-channels. It also provides a theoretical basis for the prevention of ovarian cancer and its treatment using traditional Chinese medicine in the future.
- Published
- 2021
- Full Text
- View/download PDF